GLP-1 Drug Prices Cut: Wegovy $149, Zepbound $299 on TrumpRx — “Promise Made. Promise Kept.”
On November 6, 2025, President Donald Trump announced agreements with pharmaceutical companies Eli Lilly and Novo Nordisk to reduce prices for GLP-1 obesity medications. The announcement took place in the Oval Office